Isomeric mono-, di-, and tri-bromobenzo-1H-triazoles as inhibitors of human protein kinase CK2α.

To further clarify the role of the individual bromine atoms of 4,5,6,7-tetrabromotriazole (TBBt), a relatively selective inhibitor of protein kinase CK2, we have examined the inhibition (IC(50)) of human CK2α by the two mono-, the four di-, and the two tri- bromobenzotriazoles relative to that of TB...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Romualda Wąsik, Patrycja Wińska, Jarosław Poznański, David Shugar
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2012
Materias:
R
Q
Acceso en línea:https://doaj.org/article/0c02245947ba42b8b9fea37b0dabbaef
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:0c02245947ba42b8b9fea37b0dabbaef
record_format dspace
spelling oai:doaj.org-article:0c02245947ba42b8b9fea37b0dabbaef2021-11-18T08:08:52ZIsomeric mono-, di-, and tri-bromobenzo-1H-triazoles as inhibitors of human protein kinase CK2α.1932-620310.1371/journal.pone.0048898https://doaj.org/article/0c02245947ba42b8b9fea37b0dabbaef2012-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23155426/?tool=EBIhttps://doaj.org/toc/1932-6203To further clarify the role of the individual bromine atoms of 4,5,6,7-tetrabromotriazole (TBBt), a relatively selective inhibitor of protein kinase CK2, we have examined the inhibition (IC(50)) of human CK2α by the two mono-, the four di-, and the two tri- bromobenzotriazoles relative to that of TBBt. Halogenation of the central vicinal C(5)/C(6) atoms proved to be a key factor in enhancing inhibitory activity, in that 5,6-di-Br(2)Bt and 4,5,6-Br(3)Bt were almost as effective inhibitors as TBBt, notwithstanding their marked differences in pK(a) for dissociation of the triazole proton. The decrease in pK(a) on halogenation of the peripheral C(4)/C(7) atoms virtually nullifies the gain due to hydrophobic interactions, and does not lead to a decrease in IC(50). Molecular modeling of structures of complexes of the ligands with the enzyme, as well as QSAR analysis, pointed to a balance of hydrophobic and electrostatic interactions as a discriminator of inhibitory activity. The role of halogen bonding remains debatable, as originally noted for the crystal structure of TBBt with CK2α (pdb1j91). Finally we direct attention to the promising applicability of our series of well-defined halogenated benzotriazoles to studies on inhibition of kinases other than CK2.Romualda WąsikPatrycja WińskaJarosław PoznańskiDavid ShugarPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 7, Iss 11, p e48898 (2012)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Romualda Wąsik
Patrycja Wińska
Jarosław Poznański
David Shugar
Isomeric mono-, di-, and tri-bromobenzo-1H-triazoles as inhibitors of human protein kinase CK2α.
description To further clarify the role of the individual bromine atoms of 4,5,6,7-tetrabromotriazole (TBBt), a relatively selective inhibitor of protein kinase CK2, we have examined the inhibition (IC(50)) of human CK2α by the two mono-, the four di-, and the two tri- bromobenzotriazoles relative to that of TBBt. Halogenation of the central vicinal C(5)/C(6) atoms proved to be a key factor in enhancing inhibitory activity, in that 5,6-di-Br(2)Bt and 4,5,6-Br(3)Bt were almost as effective inhibitors as TBBt, notwithstanding their marked differences in pK(a) for dissociation of the triazole proton. The decrease in pK(a) on halogenation of the peripheral C(4)/C(7) atoms virtually nullifies the gain due to hydrophobic interactions, and does not lead to a decrease in IC(50). Molecular modeling of structures of complexes of the ligands with the enzyme, as well as QSAR analysis, pointed to a balance of hydrophobic and electrostatic interactions as a discriminator of inhibitory activity. The role of halogen bonding remains debatable, as originally noted for the crystal structure of TBBt with CK2α (pdb1j91). Finally we direct attention to the promising applicability of our series of well-defined halogenated benzotriazoles to studies on inhibition of kinases other than CK2.
format article
author Romualda Wąsik
Patrycja Wińska
Jarosław Poznański
David Shugar
author_facet Romualda Wąsik
Patrycja Wińska
Jarosław Poznański
David Shugar
author_sort Romualda Wąsik
title Isomeric mono-, di-, and tri-bromobenzo-1H-triazoles as inhibitors of human protein kinase CK2α.
title_short Isomeric mono-, di-, and tri-bromobenzo-1H-triazoles as inhibitors of human protein kinase CK2α.
title_full Isomeric mono-, di-, and tri-bromobenzo-1H-triazoles as inhibitors of human protein kinase CK2α.
title_fullStr Isomeric mono-, di-, and tri-bromobenzo-1H-triazoles as inhibitors of human protein kinase CK2α.
title_full_unstemmed Isomeric mono-, di-, and tri-bromobenzo-1H-triazoles as inhibitors of human protein kinase CK2α.
title_sort isomeric mono-, di-, and tri-bromobenzo-1h-triazoles as inhibitors of human protein kinase ck2α.
publisher Public Library of Science (PLoS)
publishDate 2012
url https://doaj.org/article/0c02245947ba42b8b9fea37b0dabbaef
work_keys_str_mv AT romualdawasik isomericmonodiandtribromobenzo1htriazolesasinhibitorsofhumanproteinkinaseck2a
AT patrycjawinska isomericmonodiandtribromobenzo1htriazolesasinhibitorsofhumanproteinkinaseck2a
AT jarosławpoznanski isomericmonodiandtribromobenzo1htriazolesasinhibitorsofhumanproteinkinaseck2a
AT davidshugar isomericmonodiandtribromobenzo1htriazolesasinhibitorsofhumanproteinkinaseck2a
_version_ 1718422150851854336